Description
What it is
Dual GIP / GLP-1 receptor agonist.
Mechanism
Tirzepatide is the first dual GIP/GLP-1 receptor agonist, activating both incretin pathways to enhance glucose-dependent insulin secretion, suppress glucagon and slow gastric emptying.
Specifications
- Peptide content: 50mg / vial
- Form: Lyophilized powder
- Storage: 2–8°C, protected from light
For laboratory research only. Not for human or veterinary use.
